Compare
Abbott Laboratories vs Idexx Laboratories (ABT vs IDXX)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and Idexx Laboratories (IDXX) -6.1%; so far this year the figures are -12.3% and -0.1%.
Abbott Laboratories is the larger company by market value, about 3.6 times the size of Idexx Laboratories.
On trailing earnings, ABT trades at 40.9 times and IDXX at 45.6 times.
Revenue grew +10.0% at ABT and +11.9% at IDXX over the last year.
ABT yields 2.29%. IDXX pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | IDXX | |
|---|---|---|
| Price | $109.93 | $676.04 |
| 1-day | -3.23% | +0.79% |
| YTD | -12.26% | -0.07% |
| 1 year | -11.73% | -6.13% |
| 3 years | +15.70% | +71.00% |
| Market cap | $190.4B | $53.3B |
| P/E | 40.9 | 45.6 |
| P/S | 3.95 | 11.42 |
| P/B | 3.73 | 28.50 |
| Revenue growth | +10.00% | +11.90% |
| EPS growth | -66.20% | +17.70% |
| Gross margin % | 56.9 | 62.7 |
| Net margin % | 9.7 | 25.4 |
| ROE % | 9.2 | 63.2 |
| Debt / equity | 0.61 | 0.20 |
| FCF yield % | 3.5 | 2.4 |
| Dividend yield % | 2.29 | — |
| Beta | 0.06 | 0.79 |
| RSI (14) | 58.5 | 71.0 |
| Technical rating |